A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study Assessing the Safety and Tolerability

Clinical trial NCT01404117 · WITHDRAWN

Trial details

NCT number: NCT01404117
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2012-03-01
Primary completion: 2013-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.